Shanghai Shyndec Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -15.49% vs 19.58% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -8.04% vs 28.16% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,064.30",
          "val2": "2,442.70",
          "chgp": "-15.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "221.10",
          "val2": "283.20",
          "chgp": "-21.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.20",
          "chgp": "150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "192.10",
          "val2": "208.90",
          "chgp": "-8.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "107.10%",
          "val2": "41.10%",
          "chgp": "6.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -14.36% vs -9.36% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -14.26% vs 38.10% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,303.30",
          "val2": "10,863.70",
          "chgp": "-14.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,815.80",
          "val2": "2,302.20",
          "chgp": "-21.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "38.90",
          "chgp": "-63.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.80",
          "val2": "-10.50",
          "chgp": "82.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,142.20",
          "val2": "1,332.10",
          "chgp": "-14.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "118.00%",
          "val2": "140.30%",
          "chgp": "-2.23%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

2,064.30

2,442.70

-15.49%

Operating Profit (PBDIT) excl Other Income

221.10

283.20

-21.93%

Interest

0.50

0.20

150.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

192.10

208.90

-8.04%

Operating Profit Margin (Excl OI)

107.10%

41.10%

6.60%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -15.49% vs 19.58% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -8.04% vs 28.16% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

9,303.30

10,863.70

-14.36%

Operating Profit (PBDIT) excl Other Income

1,815.80

2,302.20

-21.13%

Interest

14.30

38.90

-63.24%

Exceptional Items

-1.80

-10.50

82.86%

Consolidate Net Profit

1,142.20

1,332.10

-14.26%

Operating Profit Margin (Excl OI)

118.00%

140.30%

-2.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -14.36% vs -9.36% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -14.26% vs 38.10% in Dec 2024

All Annual Results